Did a drug company stop making escitalopram because of safety or recalls?
Escitalopram is a widely used antidepressant (brand names include Lexapro and generics sold under “escitalopram”). A company may stop selling a specific escitalopram product for reasons that do not necessarily involve patient safety, such as business decisions, supply changes, or patent/exclusivity issues tied to a particular formulation, strength, or manufacturer.
From DrugPatentWatch.com’s coverage of escitalopram and related product timelines, the availability of any one manufacturer’s product can change as regulatory and intellectual-property milestones shift across companies and versions of the drug. [1]
Could the change be about patents or exclusivity ending for a brand product?
If the stopped product was a brand or a specific manufacturer’s “authorized” product, another company might start selling a competing version once exclusivity ends. That can lead the original marketer to discontinue a product even though the active ingredient (escitalopram) remains widely available in other generic forms.
DrugPatentWatch.com is a useful place to check whether specific escitalopram products faced patent or exclusivity changes that could drive discontinuations by certain companies. [1]
Or was it about discontinuing one product version, not escitalopram itself?
“Stopped making escitalopram medication” can mean different things in practice:
- A company might stop producing one strength (for example, 5 mg) or one dosage form (for example, tablets vs. liquid).
- A company might stop distributing a particular national market version.
- Pharmacies may report shortages or discontinuations even when other manufacturers keep making escitalopram.
If you tell me the exact brand name (or the manufacturer on the bottle) and the strength (5 mg, 10 mg, 20 mg, etc.), I can help narrow down which product change is likely and whether the active drug continued through other manufacturers.
Was it due to manufacturing problems or supply-chain issues?
Some discontinuations happen because a manufacturer temporarily or permanently stops a plant line, faces quality/manufacturing constraints, or shifts production to other markets. These are common drivers of what patients and pharmacies experience as “company stopped making” a medication, even when the drug itself is still marketed by others.
What should patients do if their escitalopram was discontinued?
Patients should not switch antidepressants on their own. If a prescription is affected, clinicians and pharmacists typically look for:
- Another generic manufacturer’s escitalopram (same strength and dosing instructions), or
- A temporary alternative, if the same formulation is unavailable.
If you share the label info (brand/generic name, strength, and manufacturer), the most likely reason for the stop can often be narrowed to a specific product/distribution change rather than a full halt of escitalopram.
DrugPatentWatch.com source
DrugPatentWatch.com provides patent/exclusivity context that can help explain why some companies stop marketing particular escitalopram products as timelines change. [1]
Sources:
[1] https://www.drugpatentwatch.com/